SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.

Cash flow Shanghai Runda Medical Technology Co., Ltd.

Stocks

603108

CNE100002318

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 2026-07-17			5-day change	1st Jan Change
9.690 ^CNY	-6.01%		+3.19%	-35.18%

Apr. 28	Shanghai Runda Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 28	Shanghai Runda Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

e3d8.gyeMoza479yY0y_TiF9LNm5eG2c_ZfE-KaXWKc-xFTE.4nbkyGHWp7Pqgl2GxzAlXAMyfTJMVIhaTMqlXKCBImnJFsLAWevYv-mKXA

Published financial data: SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	8.85B	10.49B	9.14B	8.31B	6.99B
Other Revenues, Total	6.83M	7.13M	7.15M	5.85M	7.97M
Total Revenues	8.86B	10.49B	9.15B	8.31B	7B
Cost of Goods Sold, Total	6.47B	7.56B	6.73B	6.21B	5.5B
Gross Profit	2.39B	2.93B	2.42B	2.1B	1.5B
Selling General & Admin Expenses, Total	1.24B	1.58B	1.43B	1.32B	1.19B
Provision for Bad Debts	51.66M	199M	85.53M	67.25M	176M
R&D Expenses	123M	146M	147M	116M	108M
Other Operating Expenses	24.66M	29.36M	36.64M	40.98M	24.83M
Other Operating Expenses, Total	1.44B	1.95B	1.69B	1.55B	1.5B
Operating Income	949M	979M	724M	556M	1.62M
Interest Expense, Total	-282M	-318M	-334M	-313M	-279M
Interest And Investment Income	142M	145M	255M	123M	31.78M
Net Interest Expenses	-140M	-173M	-79.1M	-190M	-247M
Currency Exchange Gains (Loss)	-4.73M	-1.65M	3.18M	-5.97M	-384K
Other Non Operating Income (Expenses)	-27.55M	6.11M	-10.01M	-22.43M	-16.97M
EBT, Excl. Unusual Items	777M	810M	638M	338M	-263M
Impairment of Goodwill	-	-	-10.41M	-29.13M	-209M
Gain (Loss) On Sale Of Investments	-7.15M	-	-	-	-
Gain (Loss) On Sale Of Assets	-1.52M	2.67M	8.73M	6.48M	-452K
Asset Writedown	-	-34.02M	-13.23M	-	-
Other Unusual Items	11.99M	40.65M	32.46M	30.12M	11.74M
EBT, Incl. Unusual Items	780M	820M	656M	346M	-461M
Income Tax Expense	182M	165M	213M	156M	57.51M
Earnings From Continuing Operations	598M	655M	443M	189M	-518M
Net Income to Company	598M	655M	443M	189M	-518M
Minority Interest	-218M	-237M	-169M	-134M	-30.24M
Net Income - (IS)	380M	418M	273M	55.28M	-548M
Net Income to Common Incl Extra Items	380M	418M	273M	55.28M	-548M
Net Income to Common Excl. Extra Items	380M	418M	273M	55.28M	-548M
Per Share Items
Net EPS - Basic	0.66	0.72	0.47	0.09	-0.91
Basic EPS - Continuing Operations	0.66	0.72	0.47	0.09	-0.91
Basic Weighted Average Shares Outstanding	576M	580M	581M	614M	603M
Net EPS - Diluted	0.64	0.7	0.47	0.09	-0.91
Diluted EPS - Continuing Operations	0.64	0.7	0.47	0.09	-0.91
Diluted Weighted Average Shares Outstanding	594M	597M	581M	614M	603M
Normalized Basic EPS	0.46	0.46	0.39	0.13	-0.32
Normalized Diluted EPS	0.45	0.45	0.39	0.13	-0.32
Dividend Per Share	-	0.15	0.1	0.03	-
Payout Ratio	71.74	58.45	138.14	610.24	-51.3
Supplemental Items
EBITDA	1.23B	1.27B	1.02B	873M	288M
EBITA	950M	979M	724M	556M	1.82M
EBIT	949M	979M	724M	556M	1.62M
EBITDAR	1.24B	1.27B	1.12B	958M	359M
Total Revenues (As Reported)	8.86B	10.49B	9.15B	8.31B	7B
Effective Tax Rate - (Ratio)	23.35	20.07	32.48	45.17	-12.49
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	204M	228M	215M	186M	114M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-21.63M	-63.45M	-2.19M	-29.57M	-56.6M
Normalized Net Income	268M	269M	229M	77.11M	-195M
Interest on Long-Term Debt	33.27M	45.86M	45.05M	35.14M	23.48M
Non-Cash Pension Expense	259K	64.04K	183K	-	-
Supplemental Operating Expense Items
Advertising Expense	58.12M	49.57M	21.28M	17.3M	11.97M
Selling and Marketing Expenses	845M	1.04B	917M	841M	749M
General and Administrative Expenses	398M	541M	490M	461M	418M
Research And Development Expense From Footnotes	123M	146M	147M	116M	108M
Net Rental Expense, Total	9.42M	326K	91.3M	85.38M	71.11M
Imputed Operating Lease Interest Expense	4.27M	132K	35.78M	30.98M	22.81M
Imputed Operating Lease Depreciation	5.16M	194K	55.53M	54.4M	48.29M
Maintenance & Repair Expenses, Total	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.02B	1.01B	1.07B	1.21B	1.02B
Trading Asset Securities, Total	25.49M	106M	58M	82.2M	130M
Total Cash And Short Term Investments	1.05B	1.11B	1.13B	1.29B	1.15B
Accounts Receivable, Total	4.29B	6.04B	5.68B	5.36B	4.64B
Other Receivables	220M	233M	201M	205M	164M
Notes Receivable	1.68M	1.68M	-	-	-
Total Receivables	4.51B	6.27B	5.88B	5.57B	4.8B
Inventory	1.5B	1.62B	1.38B	1.32B	1.73B
Other Current Assets, Total	378M	819M	1.01B	1.02B	839M
Total Current Assets	7.44B	9.82B	9.39B	9.2B	8.52B
Gross Property Plant And Equipment	2.58B	2.8B	3.06B	3.12B	3.28B
Accumulated Depreciation	-1.39B	-1.64B	-1.85B	-1.99B	-2.18B
Net Property Plant And Equipment	1.19B	1.16B	1.21B	1.13B	1.1B
Long-term Investments	1.13B	1.13B	1.21B	1.48B	1.47B
Goodwill	1.9B	1.99B	2.01B	1.98B	1.77B
Other Intangibles, Total	67.71M	69.46M	76.64M	77.33M	70.8M
Accounts Receivable Long-Term	22.41M	23.12M	23.9M	17.8M	11.25M
Deferred Tax Assets Long-Term	136M	203M	235M	257M	316M
Deferred Charges Long-Term	117M	118M	143M	153M	147M
Other Long-Term Assets, Total	16.86M	12.3M	4.69M	5.64M	9.57M
Total Assets	12.02B	14.52B	14.31B	14.31B	13.42B
Liabilities
Accounts Payable, Total	1.16B	1.84B	1.51B	1.16B	1.22B
Accrued Expenses, Total	160M	219M	148M	117M	110M
Short-term Borrowings	4.2B	5.21B	4.71B	4.92B	4.86B
Current Portion of Long-Term Debt	31.48M	620M	512M	836M	1B
Current Portion of Leases	65.29M	53.35M	265M	189M	199M
Current Income Taxes Payable	78.71M	94.03M	97.02M	68.65M	39.59M
Unearned Revenue Current, Total	195M	186M	113M	97.36M	89.63M
Other Current Liabilities	285M	285M	175M	152M	157M
Total Current Liabilities	6.18B	8.51B	7.53B	7.54B	7.68B
Long-Term Debt	1.22B	824M	1.1B	887M	633M
Long-Term Leases	178M	133M	160M	209M	168M
Unearned Revenue Non Current	31.36M	24.95M	18.25M	14.88M	11.02M
Deferred Tax Liability Non Current	10.72M	16.63M	51.86M	43.94M	42.98M
Other Non Current Liabilities	2.54M	1.62M	2.13M	2.41M	2.48M
Total Liabilities	7.62B	9.51B	8.86B	8.7B	8.54B
Common Stock, Total	580M	580M	597M	604M	604M
Additional Paid In Capital	916M	921M	1.16B	1.25B	1.25B
Retained Earnings	1.85B	2.27B	2.46B	2.45B	1.89B
Comprehensive Income and Other	115M	118M	67.12M	52.89M	42.97M
Total Common Equity	3.46B	3.89B	4.28B	4.35B	3.79B
Minority Interest	929M	1.12B	1.17B	1.25B	1.1B
Total Equity	4.39B	5.01B	5.45B	5.6B	4.88B
Total Liabilities And Equity	12.02B	14.52B	14.31B	14.31B	13.42B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	580M	580M	597M	604M	604M
ECS Total Common Shares Outstanding	580M	580M	597M	604M	604M
Book Value / Share	5.97	6.71	7.17	7.21	6.27
Tangible Book Value	1.5B	1.83B	2.19B	2.29B	1.94B
Tangible Book Value Per Share	2.58	3.16	3.67	3.8	3.22
Total Debt	5.7B	6.85B	6.75B	7.05B	6.86B
Net Debt	4.65B	5.73B	5.62B	5.76B	5.72B
Debt Equivalent Oper. Leases	75.4M	2.61M	730M	683M	569M
Minority Interest, Total (Incl. Fin. Div)	929M	1.12B	1.17B	1.25B	1.1B
Equity Method Investments, Total	1.11B	1.1B	1.17B	1.44B	1.44B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	82.75M	105M	102M	48.32M	62.27M
Inventories - Work In Process, Total	33.97M	28.91M	15.9M	26.62M	32.42M
Inventories - Finished Goods, Total	1.39B	1.49B	-	1.27B	1.65B
Inventories - Others	-	21.22K	1.28B	-	-
Buildings, Total	117M	117M	199M	199M	201M
Machinery, Total	2.07B	2.26B	2.48B	2.59B	2.77B
Full Time Employees	3.21K	3.5K	3.32K	3.14K	2.94K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	265M	469M	549M	616M	798M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	380M	418M	273M	55.28M	-548M
Depreciation & Amortization - CF	352M	369M	357M	373M	340M
Amortization of Goodwill and Intangible Assets - (CF)	388K	353K	361K	-113K	193K
Depreciation & Amortization, Total	352M	370M	357M	373M	340M
Amortization of Deferred Charges, Total - (CF)	38.01M	45.19M	43.86M	49.01M	49.88M
(Gain) Loss From Sale Of Asset	-1.73M	-6.18M	-11.77M	-11.46M	-3.12M
(Gain) Loss on Sale of Investments - (CF)	-131M	-137M	-232M	-110M	-20.79M
Asset Writedown & Restructuring Costs	3.08M	38.22M	26.69M	34.11M	213M
Provision for Credit Losses	14.31M	-20.76M	-	-	-
Provision and Write-off of Bad Debts	51.91M	198M	85.54M	81.71M	197M
Other Operating Activities, Total	507M	571M	520M	459M	310M
Change In Accounts Receivable	-669M	-2.35B	357M	-115M	-70.25M
Change In Inventories	-360M	-158M	93.37M	-72.59M	-521M
Change In Accounts Payable	207M	665M	-782M	-66.98M	749M
Change In Deferred Taxes	-21.63M	-63.45M	-2.17M	-29.57M	-56.6M
Cash from Operations	371M	-429M	730M	647M	637M
Capital Expenditure	-301M	-272M	-320M	-229M	-250M
Sale of Property, Plant, and Equipment	16.44M	20.84M	22.86M	7.96M	17.82M
Cash Acquisitions	-154M	-18.93M	-122M	-184K	-
Divestitures	-	-	99.25M	-	-
Investment in Marketable and Equity Securities, Total	-1.38M	-94.01M	-5.13M	-198M	-62.74M
Net (Increase) Decrease in Loans Originated / Sold - Investing	500K	4.33M	26.24M	-1.48M	1.4M
Other Investing Activities, Total	24.9M	37.32M	71.6M	-39.72M	54.54M
Cash from Investing	-415M	-323M	-227M	-461M	-239M
Short Term Debt Issued, Total	-	-	5M	12M	-
Long-Term Debt Issued, Total	6.45B	8.44B	10.01B	9.47B	7.7B
Total Debt Issued	6.45B	8.44B	10.02B	9.48B	7.7B
Long-Term Debt Repaid, Total	-5.51B	-7.39B	-10B	-8.82B	-7.69B
Total Debt Repaid	-5.51B	-7.39B	-10B	-8.82B	-7.69B
Issuance of Common Stock	-	-	-	28M	-
Common Dividends Paid	-273M	-244M	-378M	-337M	-281M
Common & Preferred Stock Dividends Paid	-273M	-244M	-378M	-337M	-281M
Other Financing Activities, Total	-568M	-318M	24.99M	-258M	-349M
Cash from Financing	94.95M	488M	-331M	92.3M	-619M
Foreign Exchange Rate Adjustments	-1.36M	466K	-66.54K	-2.86M	-319K
Net Change in Cash	49.63M	-263M	171M	276M	-222M
Supplemental Items
Cash Interest Paid	6.27M	9.42M	6.38M	-	-
Cash Income Tax Paid (Refund)	489M	509M	547M	549M	351M
Levered Free Cash Flow	-568M	-1.02B	226M	253M	530M
Unlevered Free Cash Flow	-391M	-820M	435M	448M	704M
Change In Net Working Capital	1.07B	1.57B	99.21M	92.1M	-564M
Net Debt Issued / Repaid	936M	1.05B	21.21M	660M	10.92M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.35	4.61	3.14	2.43	0.01
Return on Total Capital	6.44	5.57	3.76	2.8	0.01
Return On Equity %	14.12	13.94	8.47	3.43	-9.88
Return on Common Equity	11.41	11.37	6.69	1.28	-13.47
Margin Analysis
Gross Profit Margin %	27	27.93	26.44	25.28	21.39
SG&A Margin	14.04	15.04	15.58	15.89	16.96
EBITDA Margin %	13.85	12.12	11.19	10.5	4.12
EBITA Margin %	10.72	9.33	7.92	6.69	0.03
EBIT Margin %	10.71	9.32	7.91	6.69	0.02
Income From Continuing Operations Margin %	6.75	6.24	4.84	2.28	-7.4
Net Income Margin %	4.29	3.98	2.99	0.66	-7.84
Net Avail. For Common Margin %	4.29	3.98	2.99	0.66	-7.84
Normalized Net Income Margin	3.02	2.56	2.51	0.93	-2.78
Levered Free Cash Flow Margin	-6.41	-9.7	2.47	3.04	7.57
Unlevered Free Cash Flow Margin	-4.42	-7.81	4.75	5.39	10.06
Asset Turnover
Asset Turnover	0.8	0.79	0.63	0.58	0.5
Fixed Assets Turnover	8.36	8.96	7.73	7.11	6.27
Receivables Turnover (Average Receivables)	2.28	2.03	1.56	1.5	1.4
Inventory Turnover (Average Inventory)	4.87	4.85	4.5	4.6	3.6
Short Term Liquidity
Current Ratio	1.2	1.15	1.25	1.22	1.11
Quick Ratio	0.9	0.87	0.93	0.91	0.77
Operating Cash Flow to Current Liabilities	0.06	-0.05	0.1	0.09	0.08
Days Sales Outstanding (Average Receivables)	160.24	179.71	233.99	243.4	261.06
Days Outstanding Inventory (Average Inventory)	74.94	75.24	81.17	79.57	101.35
Average Days Payable Outstanding	56.25	71.31	94.01	79.22	73.42
Cash Conversion Cycle (Average Days)	178.94	183.64	221.16	243.75	289
Long Term Solvency
Total Debt/Equity	129.74	136.64	123.93	125.73	140.62
Total Debt / Total Capital	56.47	57.74	55.34	55.7	58.44
LT Debt/Equity	31.82	19.1	23.18	19.56	16.41
Long-Term Debt / Total Capital	13.85	8.07	10.35	8.66	6.82
Total Liabilities / Total Assets	63.45	65.49	61.93	60.83	63.62
EBIT / Interest Expense	3.37	3.08	2.17	1.78	0.01
EBITDA / Interest Expense	4.62	4.24	3.24	2.97	1.22
(EBITDA - Capex) / Interest Expense	3.55	3.39	2.28	2.24	0.33
Total Debt / EBITDA	4.38	5.08	6.24	7.58	20.11
Net Debt / EBITDA	3.57	4.25	5.2	6.2	16.75
Total Debt / (EBITDA - Capex)	5.7	6.36	8.86	10.07	75.52
Net Debt / (EBITDA - Capex)	4.65	5.33	7.39	8.22	62.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.33	18.45	-12.84	-9.13	-15.8
Gross Profit, 1 Yr. Growth %	25.16	22.52	-17.47	-13.03	-28.75
EBITDA, 1 Yr. Growth %	18.14	2.55	-20.37	-15.34	-68.01
EBITA, 1 Yr. Growth %	26.93	1.71	-27.05	-23.98	-99.69
EBIT, 1 Yr. Growth %	28.92	3.1	-25.99	-22.06	-99.71
Earnings From Cont. Operations, 1 Yr. Growth %	18.73	9.51	-32.43	-57.2	-373.49
Net Income, 1 Yr. Growth %	15.23	9.87	-34.58	-79.77	-1.09K
Normalized Net Income, 1 Yr. Growth %	27.42	0.51	-14.81	-65.2	-338.95
Diluted EPS Before Extra, 1 Yr. Growth %	12.28	9.38	-32.86	-80.85	-1.11K
Accounts Receivable, 1 Yr. Growth %	23.26	40.62	-5.82	-5.64	-13.55
Inventory, 1 Yr. Growth %	30.23	7.55	-14.79	-3.89	30.86
Net Property, Plant and Equip., 1 Yr. Growth %	27.28	-2.51	4.58	-6.7	-2.19
Total Assets, 1 Yr. Growth %	18.08	20.82	-1.44	-0.03	-6.21
Tangible Book Value, 1 Yr. Growth %	11.02	22.3	19.68	4.7	-15.38
Common Equity, 1 Yr. Growth %	8.1	12.29	10.07	1.74	-13.05
Cash From Operations, 1 Yr. Growth %	14.74	-215.56	-270.15	-11.34	-1.5
Capital Expenditures, 1 Yr. Growth %	-9.29	-9.62	17.55	-28.36	9.3
Levered Free Cash Flow, 1 Yr. Growth %	-28.71	79.4	-121.27	15.23	106.11
Unlevered Free Cash Flow, 1 Yr. Growth %	-39.2	109.39	-150.35	4.71	55.59
Dividend Per Share, 1 Yr. Growth %	-	-	-33.33	-70	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.09	21.84	1.61	-11	-12.53
Gross Profit, 2 Yr. CAGR %	11.82	23.84	0.56	-15.32	-21.28
EBITDA, 2 Yr. CAGR %	7.08	10.65	-9.14	-17.61	-47.12
EBITA, 2 Yr. CAGR %	6.36	14.39	-13.25	-25.16	-95.02
EBIT, 2 Yr. CAGR %	6.85	15.28	-12.67	-24.6	-95.23
Earnings From Cont. Operations, 2 Yr. CAGR %	8.19	14.03	-13.98	-46.22	8.19
Net Income, 2 Yr. CAGR %	10.84	12.52	-15.22	-63.62	41.65
Normalized Net Income, 2 Yr. CAGR %	3.13	13.17	-7.43	-46.49	-6.3
Diluted EPS Before Extra, 2 Yr. CAGR %	9.89	10.82	-14.3	-64.14	39.15
Accounts Receivable, 2 Yr. CAGR %	17.94	31.66	15.08	-5.73	-9.68
Inventory, 2 Yr. CAGR %	12.97	18.35	-4.27	-9.5	12.15
Net Property, Plant and Equip., 2 Yr. CAGR %	15.56	11.4	0.98	-1.22	-4.47
Total Assets, 2 Yr. CAGR %	15.34	19.44	9.13	-0.74	-3.17
Tangible Book Value, 2 Yr. CAGR %	23.15	16.52	20.98	11.94	-5.87
Common Equity, 2 Yr. CAGR %	12.04	10.17	11.18	5.82	-5.95
Cash From Operations, 2 Yr. CAGR %	22.66	15.15	40.23	22.82	-6.55
Capital Expenditures, 2 Yr. CAGR %	2.12	-9.46	3.07	-8.23	-11.51
Levered Free Cash Flow, 2 Yr. CAGR %	76.81	13.09	-36.91	-51.21	55.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.8	12.83	5.38	-27.94	28.25
Dividend Per Share, 2 Yr. CAGR %	-	14.71	-	-55.28	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.1	14.17	8.97	-2.11	-12.63
Gross Profit, 3 Yr. CAGR %	13.42	15.28	8.17	-4.23	-20.06
EBITDA, 3 Yr. CAGR %	9.22	5.92	-0.48	-11.05	-39.25
EBITA, 3 Yr. CAGR %	8.66	5.26	-1.07	-16.71	-87.77
EBIT, 3 Yr. CAGR %	8.99	5.58	-0.56	-16.32	-88.16
Earnings From Cont. Operations, 3 Yr. CAGR %	11.46	8.63	-4.22	-31.84	-7.52
Net Income, 3 Yr. CAGR %	13.22	10.51	-6.09	-47.42	9.49
Normalized Net Income, 3 Yr. CAGR %	7.7	2.25	2.97	-33.96	-10.27
Diluted EPS Before Extra, 3 Yr. CAGR %	12.46	9.72	-6.23	-48	9.14
Accounts Receivable, 3 Yr. CAGR %	20.77	25.06	17.75	7.71	-8.41
Inventory, 3 Yr. CAGR %	9.38	11.14	6.07	-4.14	2.34
Net Property, Plant and Equip., 3 Yr. CAGR %	10.93	9.2	9.08	-1.65	-1.54
Total Assets, 3 Yr. CAGR %	16.79	17.14	12.03	5.98	-2.59
Tangible Book Value, 3 Yr. CAGR %	22.32	22.87	17.57	15.29	1.97
Common Equity, 3 Yr. CAGR %	11.39	12.13	10.14	7.94	-0.88
Cash From Operations, 3 Yr. CAGR %	-11.69	20.24	31.16	20.35	14.11
Capital Expenditures, 3 Yr. CAGR %	4.42	-1.96	-1.23	-8.7	-2.72
Levered Free Cash Flow, 3 Yr. CAGR %	440.15	77.66	-34.29	-23.63	-20.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	47.93	36.16	-12.27	4.63	-6.56
Dividend Per Share, 3 Yr. CAGR %	-	-	-4.27	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	32.56	19.43	8.93	3.34	-0.2
Gross Profit, 5 Yr. CAGR %	31.5	19.26	8.09	1.9	-4.76
EBITDA, 5 Yr. CAGR %	31.37	14.69	1.68	-4	-22.62
EBITA, 5 Yr. CAGR %	34.65	14.65	-0.43	-7.91	-70
EBIT, 5 Yr. CAGR %	35.2	14.97	-0.25	-7.73	-70.58
Earnings From Cont. Operations, 5 Yr. CAGR %	35.25	17.12	0.49	-18	0.56
Net Income, 5 Yr. CAGR %	26.71	13.77	0.85	-29.14	10.69
Normalized Net Income, 5 Yr. CAGR %	23.63	10.26	1.37	-21.07	-1.53
Diluted EPS Before Extra, 5 Yr. CAGR %	22.71	13	0.87	-29.86	9.81
Accounts Receivable, 5 Yr. CAGR %	35.7	26.08	18.46	11.69	5.9
Inventory, 5 Yr. CAGR %	17.38	9.2	3.7	2.37	8.46
Net Property, Plant and Equip., 5 Yr. CAGR %	15.17	8.52	6.84	4.9	3.44
Total Assets, 5 Yr. CAGR %	23.95	15.3	13.66	9.63	5.69
Tangible Book Value, 5 Yr. CAGR %	-1.31	25.67	21.78	18.37	7.56
Common Equity, 5 Yr. CAGR %	10.34	11.2	11.3	9.56	3.4
Cash From Operations, 5 Yr. CAGR %	24.22	37.31	6.25	21.27	14.52
Capital Expenditures, 5 Yr. CAGR %	0.86	-4.71	3.88	-4.52	-5.48
Levered Free Cash Flow, 5 Yr. CAGR %	1.23	13.32	128.82	6.85	-7.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.84	11.45	29.17	6.67	1.82
Dividend Per Share, 5 Yr. CAGR %	-	14.57	1.03	-	-